*Corresponding author:Antonio Cassio Assis Pellizzon, Department of Radiation Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil
Received: September 21, 2018; Published: September 27, 2018
To view the Full Article Peer-reviewed Article PDF
Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still a public health problem in most developing countries. There are no significant differences between the use of high dose rate (HDR-BT) and low dose rate (LDR-BT) brachytherapy when considering overall, disease specific and recurrence free survivals. Cervical dilatation is mandatory for the insertion of intrauterine tandems in any of the techniques cited above. Pain and discomfort may eventually be limiting factors of the outpatient procedure and may lead to unsatisfactory results in terms of adequate position of the applicator set. We reviewed the current sedation and anesthetic options for comfort and safety procedures when performing HDR-BT.
Bio chemistryUniversity of Texas Medical Branch, USA
Department of Criminal JusticeLiberty University, USA
Department of PsychiatryUniversity of Kentucky, USA
Department of MedicineGally International Biomedical Research & Consulting LLC, USA
Department of Urbanisation and AgriculturalMontreal university, USA
Oral & Maxillofacial PathologyNew York University, USA
Gastroenterology and HepatologyUniversity of Alabama, UK
Department of MedicineUniversities of Bradford, UK
OncologyCirculogene Theranostics, England
Radiation ChemistryNational University of Mexico, USA
Analytical ChemistryWentworth Institute of Technology, USA
Minimally Invasive SurgeryMercer University school of Medicine, USA
Pediatric DentistryUniversity of Athens , Greece
The annual scholar awards from Lupine Publishers honor a selected number Read More...
We know the financial complexity of Individual read more...
The annual scholar awards from Lupine Publishers honor a selected number read more...